TY - JOUR
T1 - Topical cyclosporin in oral lichen planus
T2 - A controlled, randomized, prospective trial
AU - Sieg, P.
AU - Von Domarus, H.
AU - Von Zitzewitz, V.
AU - Iven, H.
AU - Farber, L.
PY - 1995
Y1 - 1995
N2 - The published studies of topical cyclosporin (CyA) therapy in chronic oral lichen planus (OLP) have shown conflicting results. We report an investigator-blinded study of 13 patients with OLP, who were randomly assigned to treatment with CyA (500 mg as a swish-and-spit medication for 5 min three times daily) or a corticosteroid oral paste (triamcinolone acetonide). The duration of treatment was 6 weeks. Thereafter, patients on corticosteroid therapy were treated with CyA, Only slight, transient clinical improvement was observed in both groups after 6 weeks of treatment, compared with baseline. No significant differences could be demonstrated between the two groups. CyA therapy following corticosteroid treatment did not produce any further clinical improvement. During follow-up of the disease for up to 1 year after treatment, neither the CyA nor the corticosteroid group exhibited long-term improvement in disease activity. Contradictory results from earlier reports are discussed.
AB - The published studies of topical cyclosporin (CyA) therapy in chronic oral lichen planus (OLP) have shown conflicting results. We report an investigator-blinded study of 13 patients with OLP, who were randomly assigned to treatment with CyA (500 mg as a swish-and-spit medication for 5 min three times daily) or a corticosteroid oral paste (triamcinolone acetonide). The duration of treatment was 6 weeks. Thereafter, patients on corticosteroid therapy were treated with CyA, Only slight, transient clinical improvement was observed in both groups after 6 weeks of treatment, compared with baseline. No significant differences could be demonstrated between the two groups. CyA therapy following corticosteroid treatment did not produce any further clinical improvement. During follow-up of the disease for up to 1 year after treatment, neither the CyA nor the corticosteroid group exhibited long-term improvement in disease activity. Contradictory results from earlier reports are discussed.
UR - https://www.scopus.com/pages/publications/0029067112
U2 - 10.1111/j.1365-2133.1995.tb00728.x
DO - 10.1111/j.1365-2133.1995.tb00728.x
M3 - Journal articles
C2 - 7772487
AN - SCOPUS:0029067112
SN - 0007-0963
VL - 132
SP - 790
EP - 794
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - 5
ER -